Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 117.47M | £ 125.02M | £ 86.94M | £ 74.09M | £ 100.46M |
Total Assets | £ 477.43M | £ 466.92M | £ 440.79M | £ 481.54M | £ 349.65M |
Total Debt | £ 4.27M | £ 3.67M | £ 5.02M | £ 5.02M | £ 6.67M |
Net Debt | £ -113.20M | £ -121.35M | £ -81.92M | £ -69.07M | £ -93.79M |
Total Liabilities | £ 267.90M | £ 282.75M | £ 271.66M | £ 318.15M | £ 204.86M |
Stockholders Equity | £ 209.53M | £ 184.17M | £ 169.14M | £ 163.39M | £ 144.79M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |